• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1070350-28
Device Problems Difficult to Remove (1528); Material Separation (1562); Material Deformation (2976); Failure to Deflate (4060)
Patient Problem Vascular Dissection (3160)
Event Date 04/22/2022
Event Type  Injury  
Manufacturer Narrative
The device is returning for analysis.It has not yet been received.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a 70% stenosed lesion in the proximal left anterior descending (lad) coronary artery.The 3.50x28mm xience xpedition stent delivery system was advanced to the lesion without issue and the stent implanted; however, the delivery system balloon failed to deflate.Multiple unsuccessful attempts were made to deflate/perforate the balloon.Finally the delivery system separated leaving the non-deflated balloon in proximal lad.After many trials to remove the balloon, it was successfully removed by trapping the balloon and removing it with the guide catheter.The stent was noted to be slightly deformed so some additional post-dilatation of the stent was performed.A proximal lad dissection was observed and another stent was implanted, successfully resolving the perforation.The patient did not experience any adverse sequela and a clinically significant delay in procedure was not reported.No additional information was provided.
 
Manufacturer Narrative
The stent delivery system was returned for analysis without the stent as the stent was implanted.The reported material separation was confirmed.The reported difficulty to remove could not be replicated in a testing environment as it was related to operational context of the procedure.The reported material deformation could not be confirmed as the stent was not returned for evaluation.The reported failure to deflate could not be confirmed due to the condition the device was received for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The reported patient effect of dissection is listed in the xience xpedition everolimus eluting coronary stent systems instructions for use (ifu) as a known patient effect of coronary stenting procedures.The investigation was unable to determine a conclusive cause for the reported failure to deflate.The shaft separation, material deformation, difficulty to remove and patient effect of dissection appear to be related to operational context of the procedure.Additionally, the reported treatments and removal of a foreign body appear to be related to operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14357858
MDR Text Key291393107
Report Number2024168-2022-05134
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeEG
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/11/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1070350-28
Device Lot Number1113041
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/29/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/06/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age61 YR
Patient Weight93 KG
-
-